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Abstract  
Purpose of review 
Magnetic resonance imaging (MRI) offers the possibility to non-invasively assess both the 
structure and function of the kidney in a single MR scan session. This review summarises 
recent advancements in functional renal MRI techniques, with a particular focus on their 
clinical relevance. 
Recent findings 
A number of MRI techniques have been developed that provide non-invasive measures of 
relevance to the pathophysiology of kidney disease. Diffusion-weighted imaging (DWI) has 
been used in chronic kidney disease (CKD) and renal transplantation, and appears promising 
as a measure of renal impairment and fibrosis. Longitudinal relaxation time (T1) mapping has 
been utilised in cardiac MRI to measure fibrosis and oedema; recent work suggests its 
potential for assessment of the kidney. Blood oxygen level dependent (BOLD) MRI to measure 
renal oxygenation has been extensively studied, but a number of other factors affect results 
making it hard to draw definite conclusions as to its utility as an independent measure. Phase 
contrast and arterial spin labelling (ASL) can measure renal artery blood flow and renal 
perfusion respectively without exogenous contrast, in contrast to dynamic contrast enhanced 
(DCE) studies. Current data on clinical use of such functional renal MR measures is largely 
restricted to cross-sectional studies.  
Summary 
Renal MRI has seen significant recent interest and advances. Current evidence demonstrates 
its potential, and next steps include wider evaluation of its clinical application.  
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Introduction 
In comparison to other specialities, advances in imaging techniques have been slow to translate in 
clinical nephrology. The potential of computerised tomography and magnetic resonance imaging 
(MRI) to provide improved structural characterisation of the kidneys has long been appreciated. 
However, these modalities are used relatively infrequently outside of specific indications such as 
renovascular disease. Renal MRI in particular is an area of immense promise and there have been 
considerable recent advances, as previously summarised [1]; the combination of highly detailed 
structural images combined with functional assessment of the kidney is particularly compelling 
(illustrated in Figure 1). In this review, we aim to summarise important recent developments in 
functional renal MRI, with a particular focus on potential clinical applications.  
 
Detection of fibrosis 
Renal fibrosis can result from acute or chronic renal injury, and it is the degree of interstitial fibrosis 
and tubular atrophy that is often the most important determinant of long-term renal outcome [2]. 
Non-invasive characterisation of fibrosis on a whole kidney basis would have significant utility in 
characterising severity of disease, assessing recovery and informing prognosis. A number of MR 
techniques show promise in this area.  
 
Diffusion-weighted MRI 
Diffusion-weighted MRI (DWI) assesses Brownian motion of water within tissues, quantified by the 
apparent diffusion coefficient (ADC). Microstructural barriers, which differ depending on tissue 
composition, determine ADC. ADC may also be affected by factors such as tubular flow and capillary 
perfusion, which can be better distinguished using the intravoxel incoherent motion (IVIM) model to 
quantify pure diffusion (ADCD). Diffusion tensor imaging (DTI) can assess the directionality of 
movement of water molecules, which provides information regarding the structural homogeneity of 
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tissues and is quantified by fractional anisotropy (FA). As an example, greater structural homogeneity 
arises from the linear arrangement of medullary tubules.  
A number of studies have used these techniques in patients with chronic kidney disease (CKD), and 
compared MRI measurements with renal function and renal biopsy. Li et al studied 12 healthy 
volunteers and 71 patients with CKD (all with chronic glomerulonephritis, GN) who had renal DWI 
within 10 days of renal biopsy [3]. Patients had glomerular filtration rate (GFR) measured using isotope 
renography. More severe histological changes on renal biopsy correlated with lower ADC values. 
However ADC values did not significantly correlate with GFR or serum creatinine concentration, and 
the usefulness of ADC values in differentiating renal pathology types was limited. Similar findings were 
reported by Zhao et al, but in their study of 35 patients with CKD (25 who had renal biopsies showing 
chronic GN), GFR and renal biopsy fibrosis scores did correlate with ADC [4]. Using DTI, a lower FA has 
been shown to be associated with the magnitude of GFR reduction and degree of fibrosis on renal 
biopsy in patients with GN (CKD stage 1-3), although there was less clear separation of FA values 
between CKD stages as compared to ADC values [5]. It should be noted that the varying methods and 
grading systems to describe histological changes, as well as the choice of DWI b-values and directions, 
raise some concerns about comparisons across studies.  
A recent patient study applied DWI and DTI in 64 patients within two weeks of renal transplantation 
(33 with immediate graft function, 31 with delayed graft function, DGF) [6]. 26 of these patients had 
transplant biopsies that were carefully analysed to quantify fibrosis, inflammation and oedema. In 
those patients with DGF, ADC in the transplant was significantly lower in the cortex and medulla, and 
FA lower in the medulla only (it was suggested that the ability of DTI to detect changes in the medulla 
but not the cortex reflected the greater structural homogeneity of the medulla). In those who had 
biopsies, both ADC and FA correlated positively with estimated GFR (eGFR) and inversely with degree 
of fibrosis, but interestingly a number of histological changes (inflammation, tubular injury score, 
capillary density, amount of oedema) had no relationship to ADC or FA. This suggests that not only 
may ADC and FA be good non-invasive measures for fibrosis, but that these measures cannot 
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differentiate between acute tubular injury and acute rejection. These data go some way to informing 
the mechanisms by which ADC and FA are reduced, implying increased cellular density and collagen 
as a direct effect of fibrosis may be more important than changes in tubular function/flow or capillary 
perfusion.  
Although there remain some knowledge gaps, particularly as to whether ADC or FA can inform long 
term prognosis and whether findings of current studies are applicable to aetiologies of CKD other than 
GN, taken together these studies suggest that DWI has a potential role in assessing degree of renal 
fibrosis.  
 
T1-mapping 
The assessment of the longitudinal (T1) relaxation time of tissue may provide an assessment of either 
fibrosis (due to association of collagen with supersaturated hydrogel) or inflammation (interstitial 
oedema, cellular swelling) [7]. T1 values have been shown to correlate well with fibrosis and oedema 
in cardiac [8] and liver imaging [9]. In an animal model of acute kidney injury (AKI) induced by 30min 
or 45min of ischaemia followed by reperfusion, Hueper et al demonstrated that the T1 relaxation time 
of renal tissue increased significantly at days 1 and 7, and was associated with renal inflammation [10]. 
At day 28, medullary and cortical tissue T1 returned towards baseline values in milder AKI, but 
remained abnormal in the more severely affected animals, correlating with persistent inflammation 
and tubular injury scores. Changes in tissue T1 at day 7 appeared to predict subsequent loss of kidney 
volume (as a marker of chronic damage) whereas histological changes did not. Whilst these results 
suggest the promise of early characterisation of AKI severity and prognosis, the method of inducing 
AKI in animal models is far removed from clinical AKI, and human studies are now needed. In a study 
of cardiorenal syndrome, Breidthardt et al showed that chronic parenchymal damage, as indicated by 
prolonged T1 relaxation, appears to underlie chronic cardiorenal syndrome rather than decreased 
perfusion [11]. 
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Renal oxygenation 
Blood oxygen level dependent (BOLD) MRI 
Hypoxia has been implicated as a key process in the progression and failed recovery of many forms of 
acute and chronic kidney disease [12, 13]. The emergence of BOLD-MRI, which can provide an 
indication of tissue oxygenation, has therefore stimulated much interest. BOLD-MRI is relatively 
simple to implement, utilising the paramagnetic affect that deoxyhaemoglobin exerts to shorten the 
transverse relaxation time constant (T2*), which is also expressed as R2* (1/T2*). Higher R2* (or lower 
T2*) is an indicator of lower tissue oxygenation (pO2). Due to their relative positions on the oxygen 
dissociation curve, BOLD-MRI is more sensitive at detecting changes in medullary as compared to 
cortical pO2. 
Despite the sometimes-demonstrated sensitivity of BOLD-MRI in animal models and healthy 
volunteers, clinical studies have produced inconsistent results. The large number of studies in CKD, 
diabetic nephropathy and kidney transplantation, with some animal studies of AKI, are summarised in 
a comprehensive review by Neugarten and Golestaneh [14]. Whereas some investigators have 
reported a reduction in oxygenation in CKD, a more recent study by Pruijm et al which compared 
healthy controls (n=45), CKD patients (n=95) and treated hypertensives (n=58) found no differences 
in cortical or medullary R2* between groups [15]. On giving a furosemide injection, medullary 
oxygenation increased in the healthy volunteers (a reduction in oxygen consumption results from 
inhibition of sodium transport in the ascending limb of the loop of Henlé) with a slight and significant 
attenuation in this response in the hypertensive and CKD groups respectively. Whilst these results may 
point away from hypoxia playing an important role in CKD, other explanations exist including BOLD-
MRI being too insensitive (particularly as it is an indirect qualitative method which may be inaccurate 
if there is heterogeneity in blood flow, oxygen delivery and consumption across the cortex and 
medulla) or that it is an attenuated response to increased oxygen demand as opposed to differences 
in baseline oxygenation that are important. Overall, the striking differences in results from studies 
make it difficult to draw firm conclusions. In part these differences may reflect issues related to both 
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the origin and analysis of BOLD-MRI data, combined with a number of clinical factors that may affect 
BOLD-MRI image intensity other than oxygenation, such as hydration status, age, haematocrit, dietary 
sodium, pH or even body temperature [1, 14]. Pohlmann et al demonstrated that T2* qualitatively 
mirrors changes in renal tissue pO2 but is also associated with confounding factors including vascular 
volume fraction and tubular volume fraction [16]. At present, additional technical advances to unravel 
these links are required before the quantitative capabilities of BOLD-MRI can be integrated to clinical 
practice, as evidenced by the failure of BOLD-MRI to discriminate between different stages of chronic 
kidney disease in 280 undifferentiated CKD patients [17]. For example, quantitative susceptibility 
mapping (QSM) is very sensitive to microstructure and chemical composition and can spatially resolve 
the source of the signal change in BOLD MRI [18]. 
 
T2-Relaxation Under Spin Tagging (TRUST) 
The relationship between the R2 tissue relaxation rate and oxygen saturation can be used to quantify 
the oxygen dependence of an organ or tissue. Using a method of T2–relaxation-under-spin-tagging 
(TRUST) MRI it is possible to enhance separation of the blood and tissue signal. In the brain, combining 
this with measures of blood flow allows the global metabolic rate of oxygen to be calculated [19]. 
Theoretically, it should be possible to apply the same methods to assess renal oxygen metabolism 
(RMRO2), providing an alternative to BOLD-MRI. Alternatively, recent studies have described the use 
of 2D multi-echo gradient and spin echo (MEGSE) or triple echo asymmetric spin echo (ASE), combined 
with Arterial Spin Labeling (ASL) to form spatial maps of RMRO2 [20]. To our knowledge, there are no 
clinical studies in this area at present.   
 
Measuring blood flow and perfusion 
Changes in large vessel flow as well as changes in tissue perfusion at the capillary level have relevance 
to a number of different renal diseases, but importantly may also provide insights into efficacy of 
therapies. Measurement of renal perfusion can be separated into those techniques that require 
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exogenous contrast agents (dynamic contrast enhanced (DCE) MRI) and those that do not (arterial 
spin labelling (ASL)).  
 
Phase contrast MRI 
Phase contrast (PC-MRI) is the current standard for the measurement of renal blood flow (RBF) in the 
renal artery and veins. PC-MRI uses the velocity-induced phase changes of moving blood to quantify 
blood flow. Apart from in patients with significant anatomical variations, this technique has been 
shown to correlate well with a number of alternative measures of renal blood flow [21]. In 11 patients 
with CKD (mean creatinine 21578mol/l) PC-MRI was used to measure RBF, and showed good 
reproducibility (coefficient of variation (CoV) of 12.9%), with RBF being significantly lower in CKD 
patients as compared with healthy volunteers [22]. Interestingly, the reproducibility of BOLD-MRI was 
better in the same cohort of patients (CoV of 8.0 %). Prowle et al demonstrated that it was possible 
to use PC-MRI to measure renal blood flow in 10 critically ill patients with AKI and sepsis. As compared 
to healthy volunteers, blood flow was reduced [23]. These pilot studies pave the way for additional 
research to understand changes in RBF across the evolution of acute and chronic kidney diseases and 
how this contributes to different pathologies, as well as assessing changes in RBF in response to 
therapy. Importantly, PC-MRI can also be applied in the aorta to provide a contemporaneous 
measurement of cardiac output, allowing assessment of RBF alongside systemic haemodynamics and 
cardiac function.  
 
Arterial spin labelling 
Arterial Spin Labelling (ASL) uses magnetically labelled water protons in blood that act as a diffusible 
tracer, providing an alternative to exogenous intravenous contrast. Tissue perfusion is determined by 
subtracting control images (no labelling applied to arterial blood) from the labelled image 
(radiofrequency magnetic labelling). Animal studies have shown that ASL can detect changes in renal 
perfusion commensurate with the degree of induced ischaemia, which correlate with histological 
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damage and change in renal function [24]. A number of recent studies have employed ASL in the 
assessment of kidney disease. In two separate studies, Rossi and Tan both used ASL to compare CKD 
patients (n=9 and n=5 respectively) with healthy volunteers and found that cortical perfusion levels 
were lower in CKD [25, 26]. ASL has also been used in AKI; Dong et al reported a reduction in both 
cortical and medullary perfusion in a group of 11 patients with AKI mostly due to intrinsic renal disease 
[27]. Although the first human study in AKI, the clinical description of the AKI episodes was limited 
with lack of clarity around timing of MRI with respect to onset or peak of AKI, severity of AKI and 
baseline CKD status. Furthermore the cross-sectional nature of the study obscured the relationship 
between ASL measurements and renal recovery. In renal transplant patients, Heusch et al employed 
ASL in a heterogeneous group of 98 renal transplant patients who underwent MRI-ASL between 3 days 
to 11 years after renal transplantation [28]. Despite the wide variation in patient selection, the results 
demonstrated that renal perfusion was lower in those patients with lower eGFR values. Importantly, 
this is one of the few studies with prospective follow up of at least six months. 12 patients, all of whom 
had reduced eGFR at baseline, subsequently had graft loss (due to a variety of reasons) and these 
patients had significantly lower baseline ASL measurements as compared to those patients with a 
baseline eGFR <30ml/min/1.73m2 who had stable transplant function. Despite this, it was difficult to 
assess how much ASL-MRI contributed to individual risk stratification because it wasn’t clear if there 
were other differences in clinical parameters or baseline eGFR levels between the patients with and 
without graft loss. Similar associations between a reduction in perfusion and GFR have been shown in 
a cross-sectional study of 62 renal transplant patients [29]. Finally, a study from our centre 
demonstrated the potential of MRI to assess response to treatment. Multiphase ASL was used to 
measure changes in renal perfusion in healthy volunteers in response to two different colloid fluid 
regimens [30].  
It is promising that the clinical studies employing ASL have so far produced relatively consistent results 
and the technique has great potential. However, there are still technical considerations that need to 
be addressed before ASL can become more widely utilised, including the variation in ASL acquisition 
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schemes that may prevent comparison between different techniques and between different MRI 
platforms, differences in post processing and complex analysis requirements.  
 
Dynamic contrast enhanced MRI 
Dynamic contrast enhanced (DCE) MRI can be used to determine renal perfusion and provide a direct 
measure of GFR but requires administration of an exogenous contrast agent. Zollner et al investigated 
the results of different pharmacokinetic models in a quantitative analysis of renal blood flow (RBF) 
and GFR in an animal model of AKI using deconvolution analysis and a two-compartment renal 
filtration model [31]. Significant differences between control and AKI animals were detected by 
functional parameters (GFR and RBF), suggesting this technique is useful to determine renal damage 
as evidenced by spatially resolved abnormal changes in renal tissue.  
Opinion is still divided as to the extent to which these techniques should be utilised in patients with 
impaired renal function in view of the association of gadolinium and nephrogenic systemic fibrosis. 
Recent studies are therefore limited to those patients with less severe reductions in eGFR and are less 
numerous as compared to those employing ASL techniques. Woodard et al used a DCE-MRI method 
that they had previously developed to automatically estimate the volume of cortex, medulla, 
collecting system, fat, and fibrosis based on the patterns of tissue enhancement following gadolinium 
administration [32]. From a larger population study of the elderly in Iceland, 493 patients with an eGFR 
>30ml/min/1.73m2 were randomly selected of whom 40% had CKD. Total and segmental (cortical and 
medullary) volumes correlated with eGFR and albuminuria, and after adjustment for these factors 
DCE-MRI measurements associated with a number of risk factors for CKD progression. Although 
prospective data are still required, the authors concluded that this automated methodology could add 
to the assessment of patients with CKD and would be easily translated onto clinical scanners. However, 
the reluctance to use DCE-MRI in patients with more advanced CKD may limit generalisability.  
 
Challenges and next steps 
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A number of challenges remain prior to functional renal MRI techniques becoming commonplace in 
the clinical environment. Some are technical barriers to their development and translation. Many of 
the newer MRI techniques (such as ASL and T1 mapping) are currently performed only in dedicated 
research centres due to the need for specialized scan sequences, intensive post-processing, or highly 
specialised support and in-house development. Some of the methodologies are not standardised and 
it is difficult to compare results from different centres. Solutions to this require a degree of unification 
in acquisition and processing across centres and across different MR platforms. Alongside this, 
collaborative infrastructure development for multicentre studies is needed around scan capabilities, 
data handling, quality assurance, processing and analysis. Collaboration with manufacturers will also 
be key for the development of improved technology, such as the use of higher field strength MR 
scanners to move renal imaging from 3 Tesla to 7 Tesla to obtain significant improvements in signal-
to-noise ratio and spatial resolution [33], or in vivo sodium (23Na) MRI of the kidneys [34].   
Secondly, there is a clear need to design and deliver clinically led studies that incorporate prospective 
follow up, so we can build on the existing evidence base that mostly comprises cross-sectional studies 
with relatively small patient numbers. There is a challenge to demonstrate how renal MRI can used to 
improve diagnosis, assist prognosis and assess response to therapies in patients with different forms 
of kidney disease.  
Finally, we propose that the strength of renal MRI lies in the potential to deliver multi-parametric 
image acquisition, to simultaneously assess structure, function, blood flow perfusion and fibrosis. By 
doing so, not only is an inclusive assessment of the kidney made but different functional techniques 
may provide complementary information to address some of the technical issues when performed in 
isolation. To illustrate this, one of our current studies evaluating MRI in patients with CKD is utilising 
structural images, angiography, phase contrast, arterial spin labelling, BOLD-MRI, DWI and DTI within 
a one hour scan protocol, relating MR results to histology, measured GFR and progression of CKD over 
the subsequent one year (Figure 2).  
Conclusion 
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The recent, exciting advances in renal MRI illustrate that complimentary measures of kidney structure 
and function are now possible within a single MR scan session that may provide unparalleled insights 
into the pathophysiology of renal disease in man. The techniques must now be tested in clinically led 
studies that demonstrate the value of this approach to clinicians; this will be essential prior to 
translation to clinical practice.  
 
Key points  
 A number of functional MRI techniques have been developed for the kidney 
 It is possible to measure renal artery blood flow, renal perfusion, oxygenation and surrogates of 
fibrosis/inflammation non-invasively and without contrast agents 
 Current data show potential value of these measurements in cross-sectional studies in CKD, AKI 
and renal transplantation 
 Next steps include studies to demonstrate clinical application and utility of these techniques  
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